The objectives of the proposed work are to study the effect of the distribution of surface positive charges of polyamines on the interactions with nucleic acids and to use these results to design and synthesize polyamine analogs with modified charge distributions that may have different affinities for nucleic acids than the naturally-occurring polyamines. The analogs should physically replace natural polyamines without duplicating at least some of their biological functions.
The specific aims are: 1) to measure the association constants of naturally-occurring polyamines and synthetic polyamine analogs with DNA and polynucleotides using Spectroscopic methods; 2) to determine whether polyamine analogs will mimic the condensation of DNA and/or the induction of the B to Z transition of specific polynucleotides caused by naturally-occurring polyamines; 3) to test the effects of specific analogs on the growth and viability of cultured human and rodent brain tumor cells; 4) to study the effects on the cytotoxicity of CENUs and Cis-Pt caused by replacement of naturally- occurring polyamines with effective analogs previously identified: and, 5) to assist the effects of analogs on DNA crosslinking caused by CENU and cis- Pt. Results obtained in Aims 1 and 2 will be used to choose and design effective analogs, and results from Aims 3-5 will allow evaluation of the effects of analogs on living cells that may lead to the design of therapeutically important anticancer agents.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA049409-03
Application #
3459330
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1990-01-01
Project End
1994-12-31
Budget Start
1992-01-01
Budget End
1992-12-31
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Basu, H S; Pellarin, M; Feuerstein, B G et al. (1996) The ability of polyamine analogues to induce Z-DNA structure in synthetic polynucleotides in vitro inversely correlates with their effects on cytotoxicity of cis-diaminedichloroplatinum (II) (CDDP) in human brain tumor cell lines. Anticancer Res 16:39-47
Harari, P M; Pickart, M A; Contreras, L et al. (1995) Slowing proliferation in head and neck tumors: in vitro growth inhibitory effects of the polyamine analog BE-4-4-4-4 in human squamous cell carcinomas. Int J Radiat Oncol Biol Phys 32:687-94
Bergeron, C J; Basu, H S; Marton, L J et al. (1995) Two polyamine analogs (BE-4-4-4 and BE-4-4-4-4) directly affect growth, survival, and cell cycle progression in two human brain tumor cell lines. Cancer Chemother Pharmacol 36:411-7
Delcros, J G; Schwartz, B; Clement, S et al. (1995) Spermine induces haemoglobin synthesis in murine erythroleukaemia cells. Biochem J 309 ( Pt 3):781-6
Schwartz, B; Hittelman, A; Daneshvar, L et al. (1995) A new model for disruption of the ornithine decarboxylase gene, SPE1, in Saccharomyces cerevisiae exhibits growth arrest and genetic instability at the MAT locus. Biochem J 312 ( Pt 1):83-90
Clement, S; Delcros, J G; Basu, H S et al. (1995) The structure of polyamine analogues determines haemoglobin production and cytotoxicity in murine erythroleukaemia cells. Biochem J 309 ( Pt 3):787-91
Wang, J; Basu, H S; Hu, L et al. (1995) Radiation-induced changes in nucleoid halo diameters of aerobic and hypoxic SF-126 human brain tumor cells. Cytometry 19:107-11
Basu, H S; Marton, L J; Pellarin, M et al. (1994) Design and testing of novel cytotoxic polyamine analogues. Cancer Res 54:6210-4
Smirnov, I V; Feuerstein, B G; Pellarin, M et al. (1994) Pretreatment with the polyamine analog 1,19-bis-(ethylamino)-5,10,15-triazanonadecane (BE-4-4-4-4) inhibits etoposide cytotoxicity in U-251 MG (NCI) human brain tumor cells. Cell Mol Biol (Noisy-le-grand) 40:975-80
Dolan, M E; Fleig, M J; Feuerstein, B G et al. (1994) Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts. Cancer Res 54:4698-702

Showing the most recent 10 out of 19 publications